Investing Profile

Steven Gillis

InvestorVC
Managing Director at ARCH Venture Partners
archventure.com/team/steve-gi...Seattle, Washington
Photo of Steven Gillis, Managing Director at ARCH Venture Partners
Your Intro Paths to Steven Gillis

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Find Steven Gillis on

cb
Current Investing Position
ARCH Venture Partners Managing Director
Investment Range
$50K - $150.0M
Sweet Spot
$25.0M
Investments On Record
39
Current Fund Size
$635.8M

Steven Gillis is on these Sector & Stage Rankings

Steven Gillis's Investments On Record (22)

CompanyStageDateRound SizeTotal Raised
EGenesis
Series DSep 2024$190M
Series CMar 2021$130M
Series BNov 2019$100M
Series AMar 2017$38M
$450M
Co-investors: Peter Hebert (Lux Capital), Isaac Ciechanover (Polaris Partners), Lucio Iannone (Leaps by Bayer), Boris Nikolic (Biomatics Capital Partners)
Vilya
Series AJun 2024$21M
Series AAug 2022$50M
$71M
Co-investors: Greg Yap (Menlo Ventures), Robert Nelsen (ARCH Venture Partners)
Proniras
Series BFeb 2024$5M
$5M
Basking Biosciences
Series AJan 2024$55M
$55M
TFC Therapeutics
Pre SeedAug 2023
Co-investors: Ludwig Schulze (Alumni Ventures )
Bitterroot Bio
Series AJun 2023$150M
$150M
Co-investors: Anthony Philippakis (GV (Google Ventures)), Andrew ElBardissi (Deerfield Management)
SonoThera
Series ADec 2022$61M
$61M
Co-investors: Lu Wang (Foothill Ventures (formerly Tsingyuan Ventures)), Lori Hu (Vertex Ventures), Tom Willis (Illumina Ventures), Brian Halak (Domain Associates), Asish Xavier (Johnson & Johnson Innovation)
Carrick Therapeutics
Series CDec 2022$60M
Series AOct 2016$95M
$160M